Gender Bias AI
Testing and Correcting Gender Bias in Healthcare AI
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-26-PA-21Jun 24, 2026
Ovarian Cancer
Oncolytic Viruses at a Turning Point: Advancing Olvi-Vec for Advanced Ovarian Cancer
David Alvaro, Ph.D.; Jason Litten, M.D.
Pharma's Almanac
PAO-04-26-CL-03Apr 21, 2026
Pain and Pregnancy
When Signals Fade: What the Acetaminophen–Autism Debate Teaches About Evidence, Design, and Causality
David Alvaro, Ph.D.
Pharma's Almanac
PAO-01-26-NI-18Jan 19, 2026
Women's Health
Sano Women’s Health Reports Positive Nonclinical EFD Safety Results for RVVC Drug Product
Sano Women's Health
PR-01-26-02Jan 7, 2026
Ovarian Cancer
Ovarian Cancer at an Inflection Point: Quantifying the Burden, Closing Gaps, and Accelerating Next-Generation Therapies
David Alvaro, Ph.D.
Pharma's Almanac
PAO-09-25-NI-03Sep 10, 2025
Clinical Data
Reunion Neuroscience Announces Positive Topline Results from RECONNECT Phase 2 Clinical Trial of RE104 for Postpartum Depression
Reunion Neuroscience
PR-08-25-NI-03Aug 19, 2025
Mental Health
The Mental Health Gender Gap: Why Women Bear the Burden
Maggie Palmiero
Pharma's Almanac
PAO-08-25-NI-09Aug 15, 2025
Autoimmune Diseases
Decoding the Gender Imbalance: How Sex, Hormones, and Immunity Collide in Autoimmune Disease
Chia Chia Sun; David Alvaro, Ph.D.
Fab Biopharma
PAO-08-25-CL-07Aug 12, 2025
Women's Health
10 Women’s Health Biotechs to Watch: Beyond the Biology, Toward Equity
Pharma's Almanac
PAO-08-25-NI-08Aug 11, 2025
Autoimmune Diseases
Pain, Misdiagnosis, and Autoimmune Disease: Untangling Complexity and Bias
Chia Chia Sun; David Alvaro, Ph.D.
Fab Biopharma
PAO-08-25-CL-03Aug 6, 2025
Women in Science
What progress has the industry made in advancing women in leadership, R&D, and clinical roles?
Pharma's Almanac
PAO-07-25-NI-13Jul 30, 2025
Fundraising
Sano Women’s Health Raises Funds to Advance Phase 2 Clinical Trials for Novel RVVC Treatment
Sano Women's Health
PR-06-25-NI-01Jun 6, 2025
Gender
The Business Case for Gender-Inclusive Pharma: Why Equity Drives Innovation, Performance, and Profit
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-25-NI-03Jun 4, 2025
Inclusive Trials
Inclusive Trials Are Better Trials: Why Women’s Health Can’t Be a Footnote Anymore
Emilee Kudla
Pharma's Almanac
PAO-05-25-NI-13May 30, 2025
Pregnancy Research
The Other Data Gap: Reimagining Clinical Research to Include Pregnant and Lactating Women
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-25-NI-09May 23, 2025
Gender Equity
Achieving Gender Equity Without Saying “Gender” or “Women”
Heather Harmon
Pharma's Almanac
PAO-05-25-NI-08May 22, 2025
Wearables
Closing the Gender Gap in Digital Health and Wearable Technologies
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-25-NI-07May 19, 2025
Women in Leadership
Breaking the Biopharma Glass Ceiling: Why Female Leadership Still Lags
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-05-25-NI-06May 19, 2025
Sex Differences
Half the Data, Half the Science: The Cost of Ignoring Sex Differences in Preclinical Research
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-25-NI-05May 15, 2025
WHI
A Reversal Isn’t a Rescue: Women’s Health Still Needs Defending
David Alvaro, Ph.D.
Pharma's Almanac
PAO-04-25-NI-14Apr 25, 2025